인슐린 펌프 시장 보고서 : 제품 유형, 유통 채널, 지역별(2026-2034년)

The global insulin pumps market size reached USD 5.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.70% during 2026-2034. The market is driven by the increasing number of people with diabetes, the rising incomes of individuals, the growing awareness about the benefits of the product, and the growing spending on healthcare.

Insulin Pumps Market Analysis:

• Major Market Drivers: The increasing prevalence of diabetes and the growing preference for insulin pump therapy are major market drivers.
• Key Market Trends: Technological advancements in insulin pump devices and rising awareness about the benefits of continuous glucose monitoring integration are insulin pumps market trends.
• Geographical Trends: Growing adoption of insulin pumps in emerging economies and increasing investment in healthcare infrastructure are some of the geographical trends.
• Competitive Landscape: The market is witnessing intensifying competition among key players, leading to product innovations and insulin pumps market recent developments. For instance, Tandem Diabetes Care announced that it has kicked off the U.S. commercial launch of its Mobi insulin patch pump.
• Challenges and Opportunities: Challenges include regulatory hurdles and reimbursement issues, while insulin pumps market opportunities lie in expanding market penetration and developing advanced insulin pump solutions.

Insulin Pumps Market Trends:

Increasing preference for insulin pump therapy

The insulin pumps market analysis shows remarkable growth due to the spike in the usage of insulin pumps. This positive outlook has outdated the traditional method of insulin injection and further improves the quality of life of the individuals. The insulin pumps offer several advantages that have resulted in their growth. The first factor is that insulin pumps offer flexibility and durability, and customizable features as well to cater to the needs and requirements of the public. They enable the patients to keep a check on their diabetic level, reduce the risk of hypoglycemia, and overall improve the living standard of the individuals. Insulin pumps reduce the usage of insulin injections, offering a subtle way of delivering insulin. The patients no longer have to carry the insulin injections with them. Moreover, the integration of continuous glucose monitoring and smartphone devices enabled patients to easily regulate and monitor their glucose levels, improve treatment accuracy, and provide the best solutions. People tend to often use insulin pumps owing to the ongoing awareness in the market. Overall, the insulin pumps have effectively changed the lives of the diabetic patients.

Increasing number of people with diabetes

The insulin pumps provide remedies for treating diabetes and maintaining overall body health. This device regulates glucose levels, reduces the risk of high blood sugar levels, and improves individuals' living standards. Patients often use insulin pumps due to their best features, like durability, flexibility, and convenience. Additionally, the collaboration of the glucose monitoring system with smartphone devices has further enhanced their utility. According to IMARC Group, the insulin pumps market 2021 value reached US$ 2.29 Billion in the United States. As patients are becoming aware of insulin pumps, there is an increased product uptake among consumers, which has positively impacted their growth in the market. As of the current year, the market in the United States is set to experience steady growth at a CAGR rate of 4.0% during 2024-2032. Therefore, government bodies of developed as well as developing countries have come up with several initiatives to improve diabetes management efficiently and has substantially increased diabetes care by promoting the technology of insulin pumps. The market players are continuously investing in research and development to manufacture user-friendly insulin pumps and upgrade them to meet consumer needs.

Rising awareness and education

The insulin pumps market overview shows that the market is driven largely by increased awareness and education regarding diabetes management and treatment options. Since people's knowledge about diabetes, as well as its complications, is on the rise, it has come to be known that keeping a healthy blood sugar level can make a difference in the outcomes of patients. Education programs offered by health care providers, favorable initiatives from patient advocacy organizations, and marketing campaigns by industry bodies regarding insulin pumps help in debunking perceptions surrounding them, which is encouraging their uptake. Healthcare professionals and patients are now better informed about how effective an insulin pump would be for their blood-sugar control, reducing hypoglycemia risk and making life better for people with diabetes. Hence, by increasing patients' knowledge base on diabetes self-care decision-making process through raising awareness and education, there is, therefore, greater acceptance of insulin pump therapy that leads to growth of the market.

Insulin Pumps Industry Segmentation:

Breakup by Product Type:

• Insulin Pumps
  • Tethered Pumps
  • Disposable/Patch Insulin Pumps
• Insulin Pump Supplies and Accessories
  • Infusion Set Insertion Devices
  • Insulin Reservoirs/Cartridges

Insulin pumps account for the majority of the market share

Insulin pumps market growth is driven by the advent of different types of insulin pumps. Tethered pumps use a catheter that is connected to an external device for continuous subcutaneous infusion of insulin. Conversely, disposable or patch insulin pumps are small wearable devices that stick directly onto the skin, thereby offering discrete and convenient ways of administrating insulin without tubes or external equipment. The expansion of the range of options when it comes to the insulin pump enables diabetic individuals to select their desired ones, hence increasing their adoption rate within society while also expanding its reach. Also, increased awareness among patients and healthcare providers, plus technological advancements in the design and functionality of these pumps, has led to a high insulin pumps market demand.

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Diabetes Clinics/ Centers
• Others

Hospital pharmacy holds the largest share of the industry

The market is majorly driven by hospital pharmacies that play a critical role in ensuring proper integration and implementation of this equipment in inpatient treatment pathways. Hospital pharmacists, as major stakeholders in drug management, work closely with healthcare teams to evaluate patients' needs, optimize therapy plans, and guarantee secure and efficient medication administration. In addition to medical supply procurement, stocking, educating patients as well as follow-up monitoring of the outcomes of the therapies applied through insulin pump support programs by hospital pharmacies. Meanwhile, such aspects are also highlighted in increasing patient acceptance, including training patients on how to use insulin pumps.

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

North America leads the market, accounting for the largest insulin pumps market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia Pacific, Europe, Latin America and the Middle East and Africa. According to the report, North America accounted for the largest market share.

A high incidence rate of diabetes, especially type 1 diabetes, leading to a demand for an insulin pump therapy as an effective treatment option is among other factors driving North America's insulin pumps market statistics. In 2021, 38.4 million Americans had diabetes. Additionally, favorable insurance policies towards reimbursement are coupled with increasing health provision professionals' knowledge about benefits linked to insulin pumps thereby steering their adoption over time into this area. Moreover, technological advancements in insulin pump technology contribute to growth in insulin pumps market price.

Key Regional Takeaways:

United States Insulin Pumps Market Analysis

The United States has the highest market share in the global insulin pumps market due to the high incidence of diabetes, positive reimbursement strategies, and robust healthcare infrastructure. Innovative technologies like tubeless and auto-insulin delivery systems have supported adoption among both Type 1 and Type 2 diabetics. Market leaders like Medtronic and Insulet Corporation have a stronghold with ongoing innovation and product releases. Increasing awareness of diabetes care, combined with increasing demand for minimally invasive products, sustains market growth. Moreover, partnerships between healthcare professionals and pump companies are improving patient access. Growing pediatric diabetic population and choice of wearable diabetes devices also drive market growth. Nonetheless, restrictive costs and insurance coverage for premium pumps are minor deterrents. Notwithstanding this, the market trend continues to be positive, with insulin therapy conducted at home being increasingly popular after COVID-19. The future direction is likely to be influenced by AI-guided closed-loop systems and interoperability with digital health platforms.

Europe Insulin Pumps Market Analysis

Europe is an important insulin pump market based on a growing diabetic population, robust government efforts, and growing patient awareness of sophisticated diabetes management therapies. Germany, the UK, and France are the front-runners in adoption based on strong healthcare infrastructures and reimbursement policies. Global and regional companies play a role in technological advancements in the form of features like Bluetooth compatibility and continuous glucose monitoring integration. Though expensive to initiate, good policies and early diagnosis campaigns fuel market growth. Furthermore, the transition away from pandemic-era home-based and remote monitoring solutions has further increased demand. Market penetration still varies unevenly within Eastern Europe, though, due to expense and lack of access to healthcare. The region's emphasis on personalized medicine and integration of digital health is indicative of high potential for growth.

Asia Pacific Insulin Pumps Market Analysis

Asia Pacific demonstrates high market potential with an increasing diabetic patient base, particularly in India and China. Increasing healthcare awareness, diabetes care initiatives by the government, and urbanization support market growth. Nevertheless, the high cost of devices and sparse insurance coverage hold back widespread usage. Local competitors are stepping into the market, providing low-cost solutions. Technological advancements and growing usage of telemedicine also favor regional growth.

Latin America Insulin Pumps Market Analysis

Latin America's insulin pumps market is expanding gradually due to increasing diabetes incidence and healthcare modernization in countries like Brazil and Mexico. Government diabetes awareness programs and improving medical infrastructure support demand. However, high pump costs and limited reimbursement policies slow market penetration. The region holds potential for growth as healthcare access and insurance coverage improve.

Middle East and Africa Insulin Pumps Market Analysis

The Middle East and Africa market remains nascent but is expected to grow due to rising diabetes prevalence, especially in Gulf countries. Government health initiatives and expanding private healthcare sectors drive demand. However, high costs and limited awareness hinder adoption, particularly in Africa. Improved healthcare funding and patient education programs are anticipated to boost market growth in the coming years.

Leading Key Players in the Insulin Pumps Industry:

The key players are taking strategic initiatives to increase their product lines, improve technological innovations, and grow their businesses. These companies are investing in the development of advanced insulin pump technologies to raise insulin pumps market revenue. They are also engaging in marketing activities to raise awareness. They are also taking customer feedback to improve product use and ensure patient satisfaction. The key players are trying hard to spread awareness about the benefits of the pump. They are fostering a culture of innovation and collaboration. They are taking all the efforts to drive insulin pumps market outlook.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• CeQur SA
• F. Hoffmann-La Roche AG
• Jiangsu Delfu medical device Co., Ltd.
• Medtronic plc
• Medzer LLC
• MicroPort Scientific Corporation
• Micro-Tech Medical, Inc.
• SOOIL Developments Co., Ltd.
• Terumo Corporation
• Ypsomed AG

Key Questions Answered in This Report

• 1.What was the size of the global insulin pumps market in 2025?
• 2.What is the expected growth rate of the global insulin pumps market during 2026-2034?
• 3.How big is the insulin pumps market?
• 4.What are the key factors driving the global insulin pumps market?
• 5.What has been the impact of COVID-19 on the global insulin pumps market?
• 6.What is the breakup of the global insulin pumps market based on the product type?
• 7.What is the breakup of the global insulin pumps market based on the distribution channel?
• 8.What are the key regions in the global insulin pumps market?
• 9.Who are the key players/companies in the global insulin pumps market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Insulin Pumps Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product Type
• 5.5 Market Breakup by Distribution Channel
• 5.6 Market Breakup by Region
• 5.7 Market Forecast

6 Market Breakup by Product Type

• 6.1 Insulin Pumps
  • 6.1.1 Market Trends
  • 6.1.2 Market Breakup by Type
    • 6.1.2.1 Tethered Pumps
      • 6.1.2.1.1 Market Trends
      • 6.1.2.1.2 Market Forecast
    • 6.1.2.2 Disposable/Patch Insulin Pumps
      • 6.1.2.2.1 Market Trends
      • 6.1.2.2.2 Market Forecast
  • 6.1.3 Market Forecast
• 6.2 Insulin Pump Supplies and Accessories
  • 6.2.1 Market Trends
  • 6.2.2 Market Breakup by Type
    • 6.2.2.1 Insulin Reservoirs/Cartridges
      • 6.2.2.1.1 Market Trends
      • 6.2.2.1.2 Market Forecast
    • 6.2.2.2 Infusion Set Insertion Devices
      • 6.2.2.2.1 Market Trends
      • 6.2.2.2.2 Market Forecast
  • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

• 7.1 Hospital Pharmacy
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Retail Pharmacy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Online Sales
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Diabetes Clinics/ Centers
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Europe
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Asia Pacific
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Middle East and Africa
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Latin America
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 CeQur SA
  • 13.3.2 F. Hoffmann-La Roche AG
  • 13.3.3 Jiangsu Delfu medical device Co., Ltd.
  • 13.3.4 Medtronic plc
  • 13.3.5 Medzer LLC
  • 13.3.6 MicroPort Scientific Corporation
  • 13.3.7 Micro-Tech Medical, Inc.
  • 13.3.8 SOOIL Developments Co., Ltd.
  • 13.3.9 Terumo Corporation
  • 13.3.10 Ypsomed AG